Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 192

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Discovery of N-[(3 R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia: Synthesis and Structure−Activity Relationship

Open access
Wishka, Donn G., Walker, Daniel P., Yates, Karen M., Reitz, Steven C., Jia, Shaojuan, Myers, Jason K., Olson, Kirk L., Jacobsen, E. Jon, Wolfe, Mark L., Groppi, Vincent E., Hanchar, Alexander J., Thornburgh, Bruce A., Cortes-Burgos, Luz A., Wong, Erik H. F., Staton, Brian A., Raub, Thomas J., Higdon, Nicole R., Wall, Theron M., Hurst, Raymond S., Walters, Rodney R., Hoffmann, William E., Hajos, Mihaly, Franklin, Stanley, Carey, Galen, Gold, Lisa H., Cook, Karen K., Sands, Steven B., Zhao, Sabrina X., Soglia, John R., Kalgutkar, Amit S., Arneric, Stephen P., Rogers, Bruce N. · 2006 · Journal of Medicinal Chemistry

Abstract

N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide (14, PHA-543,613), a novel agonist of the alpha7 neuronal nicotinic acetylcholine receptor (alpha7 nAChR), has been identified as a potential treatment of cognitive deficits in schizophrenia. Compound 14 is a potent and selective alpha7 nAChR agonist with an excellent in vitro profile. The compound is characterized by rapid brain penetration and high oral bioavailability in rat and demonstrates in vivo efficacy in auditory sensory gating and, in an in vivo model to assess cognitive performance, novel object recognition.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/jm0602413

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 192

Metadata

Authors
Wishka, D. G., Walker, D. P., Yates, K. M., Reitz, S. C., Jia, S., Myers, J. K., Olson, K. L., Jacobsen, E. J., Wolfe, M. L., Groppi, V. E., Hanchar, A. J., Thornburgh, B. A., Cortes-Burgos, L. A., Wong, E. H. F., Staton, B. A., Raub, T. J., Higdon, N. R., Wall, T. M., Hurst, R. S., Walters, R. R., Hoffmann, W. E., Hajos, M., Franklin, S., Carey, G., Gold, L. H., Cook, K. K., Sands, S. B., Zhao, S. X., Soglia, J. R., Kalgutkar, A. S., Arneric, S. P., & Rogers, B. N.
Venue
Journal of Medicinal Chemistry
Published
2006-06-10
Volume
49
Issue
14
Pages
4425-4436
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W1993337719
Cited by
192
References
4
FWCI
6.02
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discovery of N-[(3 R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia: Synthesis and Structure−Activity Relationship. https://app.cochat.ai/papers/10.1021/jm0602413
The paper
Wishka, D. G., Walker, D. P., Yates, K. M., Reitz, S. C., Jia, S., Myers, J. K., Olson, K. L., Jacobsen, E. J., Wolfe, M. L., Groppi, V. E., Hanchar, A. J., Thornburgh, B. A., Cortes-Burgos, L. A., Wong, E. H. F., Staton, B. A., Raub, T. J., Higdon, N. R., Wall, T. M., Hurst, R. S., . . . Rogers, B. N. (2006). Discovery of N-[(3 R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia: Synthesis and Structure−Activity Relationship. Journal of Medicinal Chemistry. https://doi.org/10.1021/jm0602413

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.